About us

John Lamb, PhD.

Board Member

Dr John Lamb has 12 years of experience in academia followed by a 17 year career in industry in Merck, Pfizer and Novartis involving roles at both the technical and leadership levels. He stopped work in 2018 due to sight loss (Retinitis pigmentosa). During his career Dr Lamb has worked extensively on new target identification and validation and biomarker development and personalized medicine, using systems biology/integrative genomics approaches in a broad range of therapeutic areas including oncology, metabolic diseases, cardiovascular disease, and diseases of liver, kidney, muscle and brain. His work has involved working with many teams and across all stages of the drug development pipeline, and with people of diverse backgrounds, technical skills and levels. His work has focused on strategic and tactical vision, experimental design and execution, statistical analyses and experimental follow up. He is the author of 10 patents and more than 60 publications many in the most prominent scientific journals